SCHEMBL575139

SCHEMBL575139

CCOC(=O)OCC(Cl)(Cl)Cl

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
SOAT1 P35610 1/20 0.50
LMNA P02545 3/20 0.40
HSD17B10 Q99714 1/20 0.40
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
TRPA1 O75762 1/20 0.36
PKM P14618 3/20 0.35
KDM4E B2RXH2 2/20 0.35
TSHR P16473 1/20 0.34
THRB P10828 1/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clorethate SCHEMBL41346 0.87 CHRM2 (0.39) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL1332089 0.79
SCHEMBL3673 0.79
SCHEMBL1958756 0.79 ALDH1A1 (1.00) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL4391257 0.78 ALDH1A1 (0.46) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL575201 0.78 CHRM2 (0.41) ALDH1A1LMNACHRM2CHRM4CHRM1
SCHEMBL22228982 0.78 CHRM2 (0.35) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL304788 0.78 ALDH1A1 (0.65) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL12550586 0.78 ALDH1A1 (0.65) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL877905 0.77 NAAA (0.47) ALDH1A1LMNATSHRHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2000510455-A 2000-08-15 JP claimed
EP-0896540-A1 USE OF PHOSPHONIC ACID ESTERS FOR THE TREATMENT OF FUNCTIONAL DISORDERS OF THE BRAIN AND DEPRESSION Troponwerke GmbH & Co. KG (DE) 1999-02-17 EP claimed
WO-1997039756-A1 USE OF PHOSPHONIC ACID ESTERS FOR THE TREATMENT OF FUNCTIONAL DISORDERS OF THE BRAIN AND DEPRESSION TROPONWERKE GMBH & CO. KG (DE) 1997-10-30 WO claimed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20240297344-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-05 US disclosed
US-20230253626-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY USING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2023-08-10 US disclosed
US-11688881-B2 Nonaqueous electrolytic solution and nonaqueous electrolytic solution secondary battery using same MITSUBISHI CHEMICAL CORPORATION (JP) 2023-06-27 US disclosed
US-11616253-B2 Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2023-03-28 US disclosed
CN-115066263-A Directed conjugation techniques 克莱奥药品有限公司 2022-09-16 CN disclosed
US-20220278370-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2022-09-01 US disclosed
US-20220238909-A1 SECONDARY LITHIUM-ION BATTERY ELECTROLYTE SOLUTION FOR REDUCING BATTERY RESISTANCE AND SECONDARY LITHIUM-ION BATTERY THEREOF GUANGZHOU TINCI MATERIALS TECHNOLOGY CO., LTD. (CN) 2022-07-28 US disclosed
EP-1898485-A1 NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE Mitsubishi Chemical Corporation (JP) 2008-03-12 EP disclosed
EP-1890357-A1 NONAQUEOUS ELECTROLYTE SOLUTION, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND CARBONATE COMPOUND Mitsubishi Chemical Corporation (JP) 2008-02-20 EP disclosed
EP-0896540-A1 USE OF PHOSPHONIC ACID ESTERS FOR THE TREATMENT OF FUNCTIONAL DISORDERS OF THE BRAIN AND DEPRESSION Troponwerke GmbH & Co. KG (DE) 1999-02-17 EP disclosed
WO-1997039756-A1 USE OF PHOSPHONIC ACID ESTERS FOR THE TREATMENT OF FUNCTIONAL DISORDERS OF THE BRAIN AND DEPRESSION TROPONWERKE GMBH & CO. KG (DE) 1997-10-30 WO disclosed
US-4771134-A Ring-opening process for preparing azetidinone intermediates FARMITALIA CARLO ERBA S.P.A. (IT) 1988-09-13 US disclosed
EP-0188247-A1 Process for preparing azetidinone intermediates FARMITALIA CARLO ERBA S.r.l. (IT) 1986-07-23 EP disclosed
US-4212976-A ANTIARTHRITIC AGENTS MERCK & CO., INC. (US) 1980-07-15 US disclosed
US-4057637-A RHEUMATOID ARTHRITIS MERCK & CO., INC. (US) 1977-11-08 US disclosed
US-3971797-A ANTIARTHRITIC MERCK & CO., INC. (US) 1976-07-27 US disclosed